| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
| LINC00243 |
|
long intergenic non-protein coding RNA 243
|
|
|
0.729 |
0.423 |
| HCG18 |
|
HLA complex group 18
|
|
|
0.722 |
0.538 |
| HCG17 |
|
HLA complex group 17
|
|
|
0.769 |
0.346 |
| ZNRD1ASP |
|
zinc ribbon domain containing 1 antisense, pseudogene
|
|
|
0.691 |
0.538 |
| HCG9 |
|
HLA complex group 9
|
|
|
0.700 |
0.500 |
| MSH5-SAPCD1 |
|
MSH5-SAPCD1 readthrough (NMD candidate)
|
|
|
0.760 |
0.423 |
| TRIM26BP |
|
tripartite motif containing 26B, pseudogene
|
|
|
0.861 |
0.269 |
| HLA-L |
|
major histocompatibility complex, class I, L (pseudogene)
|
|
|
0.861 |
0.269 |
| RPL18P11 |
|
ribosomal protein L18 pseudogene 11
|
|
|
0.931 |
0.077 |
| HORMAD2-AS1 |
|
HORMAD2 and MTMR3 antisense RNA 1
|
|
|
0.839 |
0.308 |
| HNRNPA1P1 |
|
heterogeneous nuclear ribonucleoprotein A1 pseudogene 1
|
|
|
0.931 |
0.154 |
| HYKK |
A2RU49
|
hydroxylysine kinase
|
|
7.3E-06 |
0.769 |
0.346 |
| MEI4 |
A8MW99
|
meiotic double-stranded break formation protein 4
|
|
|
1.000 |
0.077 |
| MSH5 |
O43196
|
mutS homolog 5
|
Nucleic acid binding
|
3.2E-11 |
0.641 |
0.692 |
| FADS1 |
O60427
|
fatty acid desaturase 1
|
|
0.37 |
0.582 |
0.769 |
| FLOT1 |
O75955
|
flotillin 1
|
|
1.0E-08 |
0.623 |
0.692 |
| APOM |
O95445
|
apolipoprotein M
|
|
9.6E-04 |
0.590 |
0.769 |
| FADS2 |
O95864
|
fatty acid desaturase 2
|
|
1.00 |
0.575 |
0.692 |
| CHEK2 |
O96017
|
checkpoint kinase 2
|
Kinase
|
1.2E-24 |
0.460 |
0.808 |
| CFB |
P00751
|
complement factor B
|
|
4.7E-16 |
0.532 |
0.769 |
| HLA-DQA2 |
P01906
|
major histocompatibility complex, class II, DQ alpha 2
|
Immune response
|
1.0E-05 |
0.617 |
0.769 |
| HLA-DQA1 |
P01909
|
major histocompatibility complex, class II, DQ alpha 1
|
Immune response
|
2.4E-02 |
0.416 |
0.846 |
| HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |